The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
Subscribe To Our Newsletter & Stay Updated